Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Expert Opinion on Drug Safety|May 9, 2019
Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysisGiovanni Galati, Moises Muley, Mauro Viganò, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2015
Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinomaMauro Viganò, Sherrie Bhoori, Pietro Lampertico, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2012
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosisMassimo Iavarone, Matteo Angelo Manini, Angelo Sangiovanni, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaCalogero Cammà, Giuseppe Cabibbo, Salvatore Petta, et al.
Palliative Medicine|August 28, 2024
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physiciansMassimo Iavarone, Lorenzo Canova, Eleonora Alimenti, et al.
Cancers|April 14, 2026
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric ApproachEleonora Alimenti, Massimo Iavarone, Elia Fracas, et al.
Journal of Hepatology|September 30, 2021
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVRRoberta D'Ambrosio, Elisabetta Degasperi, Maria Paola Anolli, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Expert Opinion on Drug Safety|May 9, 2019
Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysisGiovanni Galati, Moises Muley, Mauro Viganò, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2015
Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinomaMauro Viganò, Sherrie Bhoori, Pietro Lampertico, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2012
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosisMassimo Iavarone, Matteo Angelo Manini, Angelo Sangiovanni, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaCalogero Cammà, Giuseppe Cabibbo, Salvatore Petta, et al.
Palliative Medicine|August 28, 2024
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physiciansMassimo Iavarone, Lorenzo Canova, Eleonora Alimenti, et al.
Cancers|April 14, 2026
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric ApproachEleonora Alimenti, Massimo Iavarone, Elia Fracas, et al.
Journal of Hepatology|September 30, 2021
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVRRoberta D'Ambrosio, Elisabetta Degasperi, Maria Paola Anolli, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
Pageof 15